English

CYTOGEN CORP

EDGAR

Quarterly report (10-Q) · filed 2008-05-08

63 filing records in this dataset, filed from 1995-03-17 to 2008-05-08. Explore the available filing history and original sources.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

5.34 million USD

2008-03-31 · USD

Exact inputs and evidence

Revenue: 5339000 USD Source

Operating margin

-111.24%

2008-03-31 · %

Exact inputs and evidence

Operating Income: -5939000 USD Source
Revenue: 5339000 USD Source

Operating cash flow

-5.81 million USD

2008-03-31 · USD

Exact inputs and evidence

Operating Cash Flow: -5805000 USD Source

Free cash flow

-5.81 million USD

2008-03-31 · USD

Exact inputs and evidence

Operating Cash Flow: -5805000 USD Source
Capital Expenditure: 0 USD Source

Cash and cash equivalents: 3.09 million USD 2008-03-31 Source
Exact value

3090000 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Net income

-26.7 million USD

2007-04-01 – 2008-03-31

Exact inputs and evidence

Net income: -15228000 USD · 2007-01-01 – 2007-06-30 Source
Net income: -4832000 USD · 2007-01-01 – 2007-03-31 Source
Net income: -5119000 USD · 2007-07-01 – 2007-09-30 Source
Net income: -25692000 USD · 2007-01-01 – 2007-12-31 Source
Net income: -20346000 USD · 2007-01-01 – 2007-09-30 Source
Net income: -5858000 USD · 2008-01-01 – 2008-03-31 Source

Operating cash flow

-30.1 million USD

2007-04-01 – 2008-03-31

Exact inputs and evidence

Operating cash flow: -14835000 USD · 2007-01-01 – 2007-06-30 Source
Operating cash flow: -6787000 USD · 2007-01-01 – 2007-03-31 Source
Operating cash flow: -23418000 USD · 2007-01-01 – 2007-09-30 Source
Operating cash flow: -14835000 USD · 2007-01-01 – 2007-06-30 Source
Operating cash flow: -31129000 USD · 2007-01-01 – 2007-12-31 Source
Operating cash flow: -23418000 USD · 2007-01-01 – 2007-09-30 Source
Operating cash flow: -5805000 USD · 2008-01-01 – 2008-03-31 Source

Capital expenditure

687 thousand USD

2007-04-01 – 2008-03-31

Exact inputs and evidence

Capital expenditure: 598000 USD · 2007-01-01 – 2007-06-30 Source
Capital expenditure: 153000 USD · 2007-01-01 – 2007-03-31 Source
Capital expenditure: 711000 USD · 2007-01-01 – 2007-09-30 Source
Capital expenditure: 598000 USD · 2007-01-01 – 2007-06-30 Source
Capital expenditure: 840000 USD · 2007-01-01 – 2007-12-31 Source
Capital expenditure: 711000 USD · 2007-01-01 – 2007-09-30 Source
Capital expenditure: 0 USD · 2008-01-01 – 2008-03-31 Source

Free cash flow

-30.8 million USD

2007-04-01 – 2008-03-31

Exact inputs and evidence

Operating cash flow: -14835000 USD · 2007-01-01 – 2007-06-30 Source
Operating cash flow: -6787000 USD · 2007-01-01 – 2007-03-31 Source
Operating cash flow: -23418000 USD · 2007-01-01 – 2007-09-30 Source
Operating cash flow: -14835000 USD · 2007-01-01 – 2007-06-30 Source
Operating cash flow: -31129000 USD · 2007-01-01 – 2007-12-31 Source
Operating cash flow: -23418000 USD · 2007-01-01 – 2007-09-30 Source
Operating cash flow: -5805000 USD · 2008-01-01 – 2008-03-31 Source
Capital expenditure: 598000 USD · 2007-01-01 – 2007-06-30 Source
Capital expenditure: 153000 USD · 2007-01-01 – 2007-03-31 Source
Capital expenditure: 711000 USD · 2007-01-01 – 2007-09-30 Source
Capital expenditure: 598000 USD · 2007-01-01 – 2007-06-30 Source
Capital expenditure: 840000 USD · 2007-01-01 – 2007-12-31 Source
Capital expenditure: 711000 USD · 2007-01-01 – 2007-09-30 Source
Capital expenditure: 0 USD · 2008-01-01 – 2008-03-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2008-05-08.

Financial data available through: 2007-12-31.

Coverage by financial measure

Revenue: 11 of 11 periods available· newest 2007-12-31
Operating income: 11 of 11 periods available· newest 2007-12-31
Net income: 11 of 11 periods available· newest 2007-12-31
Operating cash flow: 11 of 11 periods available· newest 2007-12-31
Capital expenditure: 11 of 11 periods available· newest 2007-12-31
Total assets: 4 of 11 periods available· newest 2005-12-31
Total liabilities: 4 of 11 periods available· newest 2007-12-31
Current assets: 11 of 11 periods available· newest 2007-12-31
Current liabilities: 11 of 11 periods available· newest 2007-12-31
Cash and cash equivalents: 11 of 11 periods available· newest 2007-12-31
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+16.8%

Prior period

USD 17.31 million

2006-01-01 – 2006-12-31
Current period

USD 20.22 million

2007-01-01 – 2007-12-31

Exact inputs and evidence

20218000 − 17307000 = 2911000 USD

17307000 USD · 2006-01-01 – 2006-12-31
Inspect prior input Prior source
20218000 USD · 2007-01-01 – 2007-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · CYTOGEN CORP · 2007-12-31 CYTOGEN CORP (edgar:725058) Year-over-year change in Revenue: 2911000 USD Concept: fundies:Revenue Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T17:47:15Z Snapshot: 9d0200b53e978d12715361cbdd57098270ba2352acbb158e353e2872feebe7ce Dimensions: Consolidated View: https://fundies.io/companies/edgar/725058?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 20218000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/725058/0000725058-08-000009.txt#16570 Input fundies:Revenue: 17307000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/725058/0000725058-08-000009.txt#16570
The citation records this snapshot. The page link may show a newer release later.
Net income
−USD 10.59 million

Prior period

−USD 15.1 million

2006-01-01 – 2006-12-31
Current period

−USD 25.69 million

2007-01-01 – 2007-12-31

Exact inputs and evidence

-25692000 − -15103000 = -10589000 USD

-15103000 USD · 2006-01-01 – 2006-12-31
Inspect prior input Prior source
-25692000 USD · 2007-01-01 – 2007-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · CYTOGEN CORP · 2007-12-31 CYTOGEN CORP (edgar:725058) Year-over-year change in Net income: -10589000 USD Concept: fundies:NetIncome Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T17:47:15Z Snapshot: 9d0200b53e978d12715361cbdd57098270ba2352acbb158e353e2872feebe7ce Dimensions: Consolidated View: https://fundies.io/companies/edgar/725058?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -25692000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/725058/0000725058-08-000009.txt#18056 Input fundies:NetIncome: -15103000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/725058/0000725058-08-000009.txt#18056
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−USD 8.28 million

Prior period

−USD 22.85 million

2006-01-01 – 2006-12-31
Current period

−USD 31.13 million

2007-01-01 – 2007-12-31

Exact inputs and evidence

-31129000 − -22853000 = -8276000 USD

-22853000 USD · 2006-01-01 – 2006-12-31
Inspect prior input Prior source
-31129000 USD · 2007-01-01 – 2007-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · CYTOGEN CORP · 2007-12-31 CYTOGEN CORP (edgar:725058) Year-over-year change in Operating cash flow: -8276000 USD Concept: fundies:OperatingCashFlow Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T17:47:15Z Snapshot: 9d0200b53e978d12715361cbdd57098270ba2352acbb158e353e2872feebe7ce Dimensions: Consolidated View: https://fundies.io/companies/edgar/725058?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -31129000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/725058/0000725058-08-000009.txt#18377 Input fundies:OperatingCashFlow: -22853000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/725058/0000725058-08-000009.txt#18377
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+391.2%

Prior period

USD 171,000

2006-01-01 – 2006-12-31
Current period

USD 840,000

2007-01-01 – 2007-12-31

Exact inputs and evidence

840000 − 171000 = 669000 USD

171000 USD · 2006-01-01 – 2006-12-31
Inspect prior input Prior source
840000 USD · 2007-01-01 – 2007-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · CYTOGEN CORP · 2007-12-31 CYTOGEN CORP (edgar:725058) Year-over-year change in Capital expenditure: 669000 USD Concept: fundies:CapitalExpenditure Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T17:47:15Z Snapshot: 9d0200b53e978d12715361cbdd57098270ba2352acbb158e353e2872feebe7ce Dimensions: Consolidated View: https://fundies.io/companies/edgar/725058?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 840000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/725058/0000725058-08-000009.txt#18447 Input fundies:CapitalExpenditure: 171000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/725058/0000725058-08-000009.txt#18447
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2007 2007-01-01 – 2007-12-31

Revenue USD 20.22 million 100% of revenue
Operating costs Derived USD 59.76 million 296% of revenue
Operating income −USD 39.54 million −196% of revenue
Tax, interest and other Derived −USD 13.85 million −68% of revenue
Net income −USD 25.69 million −127% of revenue

Cash

Operating cash flow −USD 31.13 million −154% of revenue
Capital expenditure USD 840,000 4.2% of revenue
Free cash flow Derived −USD 31.97 million −158% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

1998 Operating loss: operating costs were 180% of revenue.
1999 Operating loss: operating costs were 151% of revenue.
2000 Operating loss: operating costs were 339% of revenue.
2001 Operating loss: operating costs were 220% of revenue.
2002 Operating loss: operating costs were 218% of revenue.
2003 Operating loss: operating costs were 174% of revenue.
2004 Operating loss: operating costs were 244% of revenue.
2005 Operating loss: operating costs were 281% of revenue.
2006 Operating loss: operating costs were 276% of revenue.
2007 Operating loss: operating costs were 296% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
1998 1998-01-01 – 1998-12-31	19879000	35794000 Derived	-15915000	-2763000 Derived	-13152000	-8125000 Derived	Source 1998-01-01 – 1998-12-31: 19879000 USD Inspect Revenue Open source 1998-01-01 – 1998-12-31: -15915000 USD Inspect Operating Income Open source 1998-01-01 – 1998-12-31: -13152000 USD Inspect Net Income Open source 1998-01-01 – 1998-12-31: -8025000 USD Inspect Operating Cash Flow Open source 1998-01-01 – 1998-12-31: 100000 USD Inspect Capital Expenditure Open source
1999 1999-01-01 – 1999-12-31	11202000	16885000 Derived	-5683000	-6412000 Derived	729000	-4400000 Derived	Source 1999-01-01 – 1999-12-31: 11202000 USD Inspect Revenue Open source 1999-01-01 – 1999-12-31: -5683000 USD Inspect Operating Income Open source 1999-01-01 – 1999-12-31: 729000 USD Inspect Net Income Open source 1999-01-01 – 1999-12-31: -3877000 USD Inspect Operating Cash Flow Open source 1999-01-01 – 1999-12-31: 523000 USD Inspect Capital Expenditure Open source
2000 2000-01-01 – 2000-12-31	10551000	35771000 Derived	-25220000	2078000 Derived	-27298000	-10247000 Derived	Source 2000-01-01 – 2000-12-31: 10551000 USD Inspect Revenue Open source 2000-01-01 – 2000-12-31: -25220000 USD Inspect Operating Income Open source 2000-01-01 – 2000-12-31: -27298000 USD Inspect Net Income Open source 2000-01-01 – 2000-12-31: -9038000 USD Inspect Operating Cash Flow Open source 2000-01-01 – 2000-12-31: 1209000 USD Inspect Capital Expenditure Open source
2001 2001-01-01 – 2001-12-31	11757000	25817000 Derived	-14060000	-1960000 Derived	-12100000	-14254000 Derived	Source 2001-01-01 – 2001-12-31: 11757000 USD Inspect Revenue Open source 2001-01-01 – 2001-12-31: -14060000 USD Inspect Operating Income Open source 2001-01-01 – 2001-12-31: -12100000 USD Inspect Net Income Open source 2001-01-01 – 2001-12-31: -13441000 USD Inspect Operating Cash Flow Open source 2001-01-01 – 2001-12-31: 813000 USD Inspect Capital Expenditure Open source
2002 2002-01-01 – 2002-12-31	12931000	28215000 Derived	-15284000	415000 Derived	-15699000	-8399000 Derived	Source 2002-01-01 – 2002-12-31: 12931000 USD Inspect Revenue Open source 2002-01-01 – 2002-12-31: -15284000 USD Inspect Operating Income Open source 2002-01-01 – 2002-12-31: -15699000 USD Inspect Net Income Open source 2002-01-01 – 2002-12-31: -8251000 USD Inspect Operating Cash Flow Open source 2002-01-01 – 2002-12-31: 148000 USD Inspect Capital Expenditure Open source
2003 2003-01-01 – 2003-12-31	13842000	24044000 Derived	-10202000	-844000 Derived	-9358000	-10627000 Derived	Source 2003-01-01 – 2003-12-31: 13842000 USD Inspect Revenue Open source 2003-01-01 – 2003-12-31: -10202000 USD Inspect Operating Income Open source 2003-01-01 – 2003-12-31: -9358000 USD Inspect Net Income Open source 2003-01-01 – 2003-12-31: -10543000 USD Inspect Operating Cash Flow Open source 2003-01-01 – 2003-12-31: 84000 USD Inspect Capital Expenditure Open source
2004 2004-01-01 – 2004-12-31	14619000	35729000 Derived	-21110000	-570000 Derived	-20540000	-18368000 Derived	Source 2004-01-01 – 2004-12-31: 14619000 USD Inspect Revenue Open source 2004-01-01 – 2004-12-31: -21110000 USD Inspect Operating Income Open source 2004-01-01 – 2004-12-31: -20540000 USD Inspect Net Income Open source 2004-01-01 – 2004-12-31: -17673000 USD Inspect Operating Cash Flow Open source 2004-01-01 – 2004-12-31: 695000 USD Inspect Capital Expenditure Open source
2005 2005-01-01 – 2005-12-31	15946000	44755000 Derived	-28809000	-2520000 Derived	-26289000	-29873000 Derived	Source 2005-01-01 – 2005-12-31: 15946000 USD Inspect Revenue Open source 2005-01-01 – 2005-12-31: -28809000 USD Inspect Operating Income Open source 2005-01-01 – 2005-12-31: -26289000 USD Inspect Net Income Open source 2005-01-01 – 2005-12-31: -29468000 USD Inspect Operating Cash Flow Open source 2005-01-01 – 2005-12-31: 405000 USD Inspect Capital Expenditure Open source
2006 2006-01-01 – 2006-12-31	17307000	47737000 Derived	-30430000	-15327000 Derived	-15103000	-23024000 Derived	Source 2006-01-01 – 2006-12-31: 17307000 USD Inspect Revenue Open source 2006-01-01 – 2006-12-31: -30430000 USD Inspect Operating Income Open source 2006-01-01 – 2006-12-31: -15103000 USD Inspect Net Income Open source 2006-01-01 – 2006-12-31: -22853000 USD Inspect Operating Cash Flow Open source 2006-01-01 – 2006-12-31: 171000 USD Inspect Capital Expenditure Open source
2007 2007-01-01 – 2007-12-31	20218000	59757000 Derived	-39539000	-13847000 Derived	-25692000	-31969000 Derived	Source 2007-01-01 – 2007-12-31: 20218000 USD Inspect Revenue Open source 2007-01-01 – 2007-12-31: -39539000 USD Inspect Operating Income Open source 2007-01-01 – 2007-12-31: -25692000 USD Inspect Net Income Open source 2007-01-01 – 2007-12-31: -31129000 USD Inspect Operating Cash Flow Open source 2007-01-01 – 2007-12-31: 840000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 20.2M 2007

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
19981998-12-31	Revenue	19879000	Revenue: 19879000 Open source
19991999-12-31	Revenue	11202000	Revenue: 11202000 Open source
20002000-12-31	Revenue	10551000	Revenue: 10551000 Open source
20012001-12-31	Revenue	11757000	Revenue: 11757000 Open source
20022002-12-31	Revenue	12931000	Revenue: 12931000 Open source
20032003-12-31	Revenue	13842000	Revenue: 13842000 Open source
20042004-12-31	Revenue	14619000	Revenue: 14619000 Open source
20052005-12-31	Revenue	15946000	Revenue: 15946000 Open source
20062006-12-31	Revenue	17307000	Revenue: 17307000 Open source
20072007-12-31	Revenue	20218000	Revenue: 20218000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

16.8% 2007

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
19981998-12-31	Year over year	37.9%	Revenue: 19879000 Open source Revenue: 14420000 Open source
19991999-12-31	Year over year	-43.6%	Revenue: 11202000 Open source Revenue: 19879000 Open source
20002000-12-31	Year over year	-5.8%	Revenue: 10551000 Open source Revenue: 11202000 Open source
20012001-12-31	Year over year	11.4%	Revenue: 11757000 Open source Revenue: 10551000 Open source
20022002-12-31	Year over year	10%	Revenue: 12931000 Open source Revenue: 11757000 Open source
20032003-12-31	Year over year	7%	Revenue: 13842000 Open source Revenue: 12931000 Open source
20042004-12-31	Year over year	5.6%	Revenue: 14619000 Open source Revenue: 13842000 Open source
20052005-12-31	Year over year	9.1%	Revenue: 15946000 Open source Revenue: 14619000 Open source
20062006-12-31	Year over year	8.5%	Revenue: 17307000 Open source Revenue: 15946000 Open source
20072007-12-31	Year over year	16.8%	Revenue: 20218000 Open source Revenue: 17307000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -195.6% 2007

Net margin -127.1% 2007

Free cash flow margin -158.1% 2007

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
19981998-12-31	Operating margin	-80.1%	Operating Income: -15915000 Open source Revenue: 19879000 Open source
19991999-12-31	Operating margin	-50.7%	Operating Income: -5683000 Open source Revenue: 11202000 Open source
20002000-12-31	Operating margin	-239%	Operating Income: -25220000 Open source Revenue: 10551000 Open source
20012001-12-31	Operating margin	-119.6%	Operating Income: -14060000 Open source Revenue: 11757000 Open source
20022002-12-31	Operating margin	-118.2%	Operating Income: -15284000 Open source Revenue: 12931000 Open source
20032003-12-31	Operating margin	-73.7%	Operating Income: -10202000 Open source Revenue: 13842000 Open source
20042004-12-31	Operating margin	-144.4%	Operating Income: -21110000 Open source Revenue: 14619000 Open source
20052005-12-31	Operating margin	-180.7%	Operating Income: -28809000 Open source Revenue: 15946000 Open source
20062006-12-31	Operating margin	-175.8%	Operating Income: -30430000 Open source Revenue: 17307000 Open source
20072007-12-31	Operating margin	-195.6%	Operating Income: -39539000 Open source Revenue: 20218000 Open source
19981998-12-31	Net margin	-66.2%	Net Income: -13152000 Open source Revenue: 19879000 Open source
19991999-12-31	Net margin	6.5%	Net Income: 729000 Open source Revenue: 11202000 Open source
20002000-12-31	Net margin	-258.7%	Net Income: -27298000 Open source Revenue: 10551000 Open source
20012001-12-31	Net margin	-102.9%	Net Income: -12100000 Open source Revenue: 11757000 Open source
20022002-12-31	Net margin	-121.4%	Net Income: -15699000 Open source Revenue: 12931000 Open source
20032003-12-31	Net margin	-67.6%	Net Income: -9358000 Open source Revenue: 13842000 Open source
20042004-12-31	Net margin	-140.5%	Net Income: -20540000 Open source Revenue: 14619000 Open source
20052005-12-31	Net margin	-164.9%	Net Income: -26289000 Open source Revenue: 15946000 Open source
20062006-12-31	Net margin	-87.3%	Net Income: -15103000 Open source Revenue: 17307000 Open source
20072007-12-31	Net margin	-127.1%	Net Income: -25692000 Open source Revenue: 20218000 Open source
19981998-12-31	Free cash flow margin	-40.9%	Revenue: 19879000 Open source Operating Cash Flow: -8025000 Open source Capital Expenditure: 100000 Open source
19991999-12-31	Free cash flow margin	-39.3%	Revenue: 11202000 Open source Operating Cash Flow: -3877000 Open source Capital Expenditure: 523000 Open source
20002000-12-31	Free cash flow margin	-97.1%	Revenue: 10551000 Open source Operating Cash Flow: -9038000 Open source Capital Expenditure: 1209000 Open source
20012001-12-31	Free cash flow margin	-121.2%	Revenue: 11757000 Open source Operating Cash Flow: -13441000 Open source Capital Expenditure: 813000 Open source
20022002-12-31	Free cash flow margin	-65%	Revenue: 12931000 Open source Operating Cash Flow: -8251000 Open source Capital Expenditure: 148000 Open source
20032003-12-31	Free cash flow margin	-76.8%	Revenue: 13842000 Open source Operating Cash Flow: -10543000 Open source Capital Expenditure: 84000 Open source
20042004-12-31	Free cash flow margin	-125.6%	Revenue: 14619000 Open source Operating Cash Flow: -17673000 Open source Capital Expenditure: 695000 Open source
20052005-12-31	Free cash flow margin	-187.3%	Revenue: 15946000 Open source Operating Cash Flow: -29468000 Open source Capital Expenditure: 405000 Open source
20062006-12-31	Free cash flow margin	-133%	Revenue: 17307000 Open source Operating Cash Flow: -22853000 Open source Capital Expenditure: 171000 Open source
20072007-12-31	Free cash flow margin	-158.1%	Revenue: 20218000 Open source Operating Cash Flow: -31129000 Open source Capital Expenditure: 840000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -31.1M 2007

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19981998-12-31	Operating cash flow	-8025000	Operating Cash Flow: -8025000 Open source
19991999-12-31	Operating cash flow	-3877000	Operating Cash Flow: -3877000 Open source
20002000-12-31	Operating cash flow	-9038000	Operating Cash Flow: -9038000 Open source
20012001-12-31	Operating cash flow	-13441000	Operating Cash Flow: -13441000 Open source
20022002-12-31	Operating cash flow	-8251000	Operating Cash Flow: -8251000 Open source
20032003-12-31	Operating cash flow	-10543000	Operating Cash Flow: -10543000 Open source
20042004-12-31	Operating cash flow	-17673000	Operating Cash Flow: -17673000 Open source
20052005-12-31	Operating cash flow	-29468000	Operating Cash Flow: -29468000 Open source
20062006-12-31	Operating cash flow	-22853000	Operating Cash Flow: -22853000 Open source
20072007-12-31	Operating cash flow	-31129000	Operating Cash Flow: -31129000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -32M 2007

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19981998-12-31	Free cash flow	-8125000	Operating Cash Flow: -8025000 Open source Capital Expenditure: 100000 Open source
19991999-12-31	Free cash flow	-4400000	Operating Cash Flow: -3877000 Open source Capital Expenditure: 523000 Open source
20002000-12-31	Free cash flow	-10247000	Operating Cash Flow: -9038000 Open source Capital Expenditure: 1209000 Open source
20012001-12-31	Free cash flow	-14254000	Operating Cash Flow: -13441000 Open source Capital Expenditure: 813000 Open source
20022002-12-31	Free cash flow	-8399000	Operating Cash Flow: -8251000 Open source Capital Expenditure: 148000 Open source
20032003-12-31	Free cash flow	-10627000	Operating Cash Flow: -10543000 Open source Capital Expenditure: 84000 Open source
20042004-12-31	Free cash flow	-18368000	Operating Cash Flow: -17673000 Open source Capital Expenditure: 695000 Open source
20052005-12-31	Free cash flow	-29873000	Operating Cash Flow: -29468000 Open source Capital Expenditure: 405000 Open source
20062006-12-31	Free cash flow	-23024000	Operating Cash Flow: -22853000 Open source Capital Expenditure: 171000 Open source
20072007-12-31	Free cash flow	-31969000	Operating Cash Flow: -31129000 Open source Capital Expenditure: 840000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

670.3% 2005

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
1998-12-31	Liabilities / assets	Not reported	Total Assets: 10900000 Open source
1999-12-31	Liabilities / assets	Not reported	Total Assets: 18605000 Open source
2000-12-31	Liabilities / assets	Not reported	No source recorded
2001-12-31	Liabilities / assets	Not reported	No source recorded
2002-12-31	Liabilities / assets	Not reported	No source recorded
2003-12-31	Liabilities / assets	Not reported	No source recorded
20042004-12-31	Liabilities / assets	Not reported	Total Liabilities: 10383000 Open source
20052005-12-31	Liabilities / assets	670.3%	Total Liabilities: 7212000 Open source Total Assets: 1076000 Open source
20062006-12-31	Liabilities / assets	Not reported	Total Liabilities: 16691000 Open source
20072007-12-31	Liabilities / assets	Not reported	Total Liabilities: 9638000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

2.04× 2007

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
19981998-12-31	Current assets / current liabilities	0.91×	Current Assets: 7457000 Open source Current Liabilities: 8234000 Open source
19991999-12-31	Current assets / current liabilities	2.78×	Current Assets: 15694000 Open source Current Liabilities: 5640000 Open source
20002000-12-31	Current assets / current liabilities	2.03×	Current Assets: 16719000 Open source Current Liabilities: 8228000 Open source
20012001-12-31	Current assets / current liabilities	3×	Current Assets: 17806000 Open source Current Liabilities: 5926000 Open source
20022002-12-31	Current assets / current liabilities	3.76×	Current Assets: 18408000 Open source Current Liabilities: 4892000 Open source
20032003-12-31	Current assets / current liabilities	6.64×	Current Assets: 34522000 Open source Current Liabilities: 5201000 Open source
20042004-12-31	Current assets / current liabilities	4.1×	Current Assets: 42354000 Open source Current Liabilities: 10336000 Open source
20052005-12-31	Current assets / current liabilities	6.97×	Current Assets: 36922000 Open source Current Liabilities: 5297000 Open source
20062006-12-31	Current assets / current liabilities	3.93×	Current Assets: 39985000 Open source Current Liabilities: 10168000 Open source
20072007-12-31	Current assets / current liabilities	2.04×	Current Assets: 17487000 Open source Current Liabilities: 8577000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
1998 1998-01-01 – 1998-12-31	−USD 13.15 million Exact value Exact value: -13152000 USD 1998-01-01 – 1998-12-31: -13152000 USD Inspect Net Income Open source Share or cite Citation for Net Income · CYTOGEN CORP · 1998-12-31 CYTOGEN CORP (edgar:725058) Net Income: -13152000 USD Concept: fundies:NetIncome Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T17:47:15Z Snapshot: 9d0200b53e978d12715361cbdd57098270ba2352acbb158e353e2872feebe7ce Dimensions: Consolidated View: https://fundies.io/companies/edgar/725058/explain?concept=fundies%3ANetIncome&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:NetIncome: -13152000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/725058/0000725058-01-000002.txt#4311 The citation records this snapshot. The page link may show a newer release later.	−USD 8.03 million Exact value Exact value: -8025000 USD 1998-01-01 – 1998-12-31: -8025000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CYTOGEN CORP · 1998-12-31 CYTOGEN CORP (edgar:725058) Operating Cash Flow: -8025000 USD Concept: fundies:OperatingCashFlow Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T17:47:15Z Snapshot: 9d0200b53e978d12715361cbdd57098270ba2352acbb158e353e2872feebe7ce Dimensions: Consolidated View: https://fundies.io/companies/edgar/725058/explain?concept=fundies%3AOperatingCashFlow&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -8025000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/725058/0000725058-01-000002.txt#4337 The citation records this snapshot. The page link may show a newer release later.	USD 100,000 Exact value Exact value: 100000 USD 1998-01-01 – 1998-12-31: 100000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CYTOGEN CORP · 1998-12-31 CYTOGEN CORP (edgar:725058) Capital Expenditure: 100000 USD Concept: fundies:CapitalExpenditure Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T17:47:15Z Snapshot: 9d0200b53e978d12715361cbdd57098270ba2352acbb158e353e2872feebe7ce Dimensions: Consolidated View: https://fundies.io/companies/edgar/725058/explain?concept=fundies%3ACapitalExpenditure&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 100000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/725058/0000725058-01-000002.txt#4345 The citation records this snapshot. The page link may show a newer release later.	−USD 8.13 million Calculation and evidence -8025000 − 100000 USD Exact free cash flow: -8125000 USD 1998-01-01 – 1998-12-31: -8025000 USD · Inspect Operating Cash Flow · Source 1998-01-01 – 1998-12-31: 100000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CYTOGEN CORP · 1998-12-31 CYTOGEN CORP (edgar:725058) Free cash flow: -8125000 USD Concept: free-cash-flow Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T17:47:15Z Snapshot: 9d0200b53e978d12715361cbdd57098270ba2352acbb158e353e2872feebe7ce Dimensions: Consolidated View: https://fundies.io/companies/edgar/725058?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -8025000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/725058/0000725058-01-000002.txt#4337 Input fundies:CapitalExpenditure: 100000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/725058/0000725058-01-000002.txt#4345 The citation records this snapshot. The page link may show a newer release later.
1999 1999-01-01 – 1999-12-31	USD 729,000 Exact value Exact value: 729000 USD 1999-01-01 – 1999-12-31: 729000 USD Inspect Net Income Open source Share or cite Citation for Net Income · CYTOGEN CORP · 1999-12-31 CYTOGEN CORP (edgar:725058) Net Income: 729000 USD Concept: fundies:NetIncome Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T17:47:15Z Snapshot: 9d0200b53e978d12715361cbdd57098270ba2352acbb158e353e2872feebe7ce Dimensions: Consolidated View: https://fundies.io/companies/edgar/725058/explain?concept=fundies%3ANetIncome&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:NetIncome: 729000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/725058/0000725058-02-000003.txt#4577 The citation records this snapshot. The page link may show a newer release later.	−USD 3.88 million Exact value Exact value: -3877000 USD 1999-01-01 – 1999-12-31: -3877000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CYTOGEN CORP · 1999-12-31 CYTOGEN CORP (edgar:725058) Operating Cash Flow: -3877000 USD Concept: fundies:OperatingCashFlow Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T17:47:15Z Snapshot: 9d0200b53e978d12715361cbdd57098270ba2352acbb158e353e2872feebe7ce Dimensions: Consolidated View: https://fundies.io/companies/edgar/725058/explain?concept=fundies%3AOperatingCashFlow&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -3877000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/725058/0000725058-02-000003.txt#4601 The citation records this snapshot. The page link may show a newer release later.	USD 523,000 Exact value Exact value: 523000 USD 1999-01-01 – 1999-12-31: 523000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CYTOGEN CORP · 1999-12-31 CYTOGEN CORP (edgar:725058) Capital Expenditure: 523000 USD Concept: fundies:CapitalExpenditure Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T17:47:15Z Snapshot: 9d0200b53e978d12715361cbdd57098270ba2352acbb158e353e2872feebe7ce Dimensions: Consolidated View: https://fundies.io/companies/edgar/725058/explain?concept=fundies%3ACapitalExpenditure&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 523000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/725058/0000725058-02-000003.txt#4605 The citation records this snapshot. The page link may show a newer release later.	−USD 4.4 million Calculation and evidence -3877000 − 523000 USD Exact free cash flow: -4400000 USD 1999-01-01 – 1999-12-31: -3877000 USD · Inspect Operating Cash Flow · Source 1999-01-01 – 1999-12-31: 523000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CYTOGEN CORP · 1999-12-31 CYTOGEN CORP (edgar:725058) Free cash flow: -4400000 USD Concept: free-cash-flow Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T17:47:15Z Snapshot: 9d0200b53e978d12715361cbdd57098270ba2352acbb158e353e2872feebe7ce Dimensions: Consolidated View: https://fundies.io/companies/edgar/725058?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -3877000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/725058/0000725058-02-000003.txt#4601 Input fundies:CapitalExpenditure: 523000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/725058/0000725058-02-000003.txt#4605 The citation records this snapshot. The page link may show a newer release later.
2000 2000-01-01 – 2000-12-31	−USD 27.3 million Exact value Exact value: -27298000 USD 2000-01-01 – 2000-12-31: -27298000 USD Inspect Net Income Open source Share or cite Citation for Net Income · CYTOGEN CORP · 2000-12-31 CYTOGEN CORP (edgar:725058) Net Income: -27298000 USD Concept: fundies:NetIncome Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T17:47:15Z Snapshot: 9d0200b53e978d12715361cbdd57098270ba2352acbb158e353e2872feebe7ce Dimensions: Consolidated View: https://fundies.io/companies/edgar/725058/explain?concept=fundies%3ANetIncome&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:NetIncome: -27298000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/725058/0000725058-03-000040.txt#4600 The citation records this snapshot. The page link may show a newer release later.	−USD 9.04 million Exact value Exact value: -9038000 USD 2000-01-01 – 2000-12-31: -9038000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CYTOGEN CORP · 2000-12-31 CYTOGEN CORP (edgar:725058) Operating Cash Flow: -9038000 USD Concept: fundies:OperatingCashFlow Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T17:47:15Z Snapshot: 9d0200b53e978d12715361cbdd57098270ba2352acbb158e353e2872feebe7ce Dimensions: Consolidated View: https://fundies.io/companies/edgar/725058/explain?concept=fundies%3AOperatingCashFlow&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -9038000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/725058/0000725058-03-000040.txt#4620 The citation records this snapshot. The page link may show a newer release later.	USD 1.21 million Exact value Exact value: 1209000 USD 2000-01-01 – 2000-12-31: 1209000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CYTOGEN CORP · 2000-12-31 CYTOGEN CORP (edgar:725058) Capital Expenditure: 1209000 USD Concept: fundies:CapitalExpenditure Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T17:47:15Z Snapshot: 9d0200b53e978d12715361cbdd57098270ba2352acbb158e353e2872feebe7ce Dimensions: Consolidated View: https://fundies.io/companies/edgar/725058/explain?concept=fundies%3ACapitalExpenditure&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1209000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/725058/0000725058-03-000040.txt#4624 The citation records this snapshot. The page link may show a newer release later.	−USD 10.25 million Calculation and evidence -9038000 − 1209000 USD Exact free cash flow: -10247000 USD 2000-01-01 – 2000-12-31: -9038000 USD · Inspect Operating Cash Flow · Source 2000-01-01 – 2000-12-31: 1209000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CYTOGEN CORP · 2000-12-31 CYTOGEN CORP (edgar:725058) Free cash flow: -10247000 USD Concept: free-cash-flow Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T17:47:15Z Snapshot: 9d0200b53e978d12715361cbdd57098270ba2352acbb158e353e2872feebe7ce Dimensions: Consolidated View: https://fundies.io/companies/edgar/725058?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -9038000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/725058/0000725058-03-000040.txt#4620 Input fundies:CapitalExpenditure: 1209000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/725058/0000725058-03-000040.txt#4624 The citation records this snapshot. The page link may show a newer release later.
2001 2001-01-01 – 2001-12-31	−USD 12.1 million Exact value Exact value: -12100000 USD 2001-01-01 – 2001-12-31: -12100000 USD Inspect Net Income Open source Share or cite Citation for Net Income · CYTOGEN CORP · 2001-12-31 CYTOGEN CORP (edgar:725058) Net Income: -12100000 USD Concept: fundies:NetIncome Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T17:47:15Z Snapshot: 9d0200b53e978d12715361cbdd57098270ba2352acbb158e353e2872feebe7ce Dimensions: Consolidated View: https://fundies.io/companies/edgar/725058/explain?concept=fundies%3ANetIncome&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:NetIncome: -12100000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/725058/0001193125-04-042097.txt#8646 The citation records this snapshot. The page link may show a newer release later.	−USD 13.44 million Exact value Exact value: -13441000 USD 2001-01-01 – 2001-12-31: -13441000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CYTOGEN CORP · 2001-12-31 CYTOGEN CORP (edgar:725058) Operating Cash Flow: -13441000 USD Concept: fundies:OperatingCashFlow Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T17:47:15Z Snapshot: 9d0200b53e978d12715361cbdd57098270ba2352acbb158e353e2872feebe7ce Dimensions: Consolidated View: https://fundies.io/companies/edgar/725058/explain?concept=fundies%3AOperatingCashFlow&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -13441000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/725058/0001193125-04-042097.txt#8870 The citation records this snapshot. The page link may show a newer release later.	USD 813,000 Exact value Exact value: 813000 USD 2001-01-01 – 2001-12-31: 813000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CYTOGEN CORP · 2001-12-31 CYTOGEN CORP (edgar:725058) Capital Expenditure: 813000 USD Concept: fundies:CapitalExpenditure Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T17:47:15Z Snapshot: 9d0200b53e978d12715361cbdd57098270ba2352acbb158e353e2872feebe7ce Dimensions: Consolidated View: https://fundies.io/companies/edgar/725058/explain?concept=fundies%3ACapitalExpenditure&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 813000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/725058/0001193125-04-042097.txt#8917 The citation records this snapshot. The page link may show a newer release later.	−USD 14.25 million Calculation and evidence -13441000 − 813000 USD Exact free cash flow: -14254000 USD 2001-01-01 – 2001-12-31: -13441000 USD · Inspect Operating Cash Flow · Source 2001-01-01 – 2001-12-31: 813000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CYTOGEN CORP · 2001-12-31 CYTOGEN CORP (edgar:725058) Free cash flow: -14254000 USD Concept: free-cash-flow Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T17:47:15Z Snapshot: 9d0200b53e978d12715361cbdd57098270ba2352acbb158e353e2872feebe7ce Dimensions: Consolidated View: https://fundies.io/companies/edgar/725058?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -13441000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/725058/0001193125-04-042097.txt#8870 Input fundies:CapitalExpenditure: 813000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/725058/0001193125-04-042097.txt#8917 The citation records this snapshot. The page link may show a newer release later.
2002 2002-01-01 – 2002-12-31	−USD 15.7 million Exact value Exact value: -15699000 USD 2002-01-01 – 2002-12-31: -15699000 USD Inspect Net Income Open source Share or cite Citation for Net Income · CYTOGEN CORP · 2002-12-31 CYTOGEN CORP (edgar:725058) Net Income: -15699000 USD Concept: fundies:NetIncome Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T17:47:15Z Snapshot: 9d0200b53e978d12715361cbdd57098270ba2352acbb158e353e2872feebe7ce Dimensions: Consolidated View: https://fundies.io/companies/edgar/725058/explain?concept=fundies%3ANetIncome&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:NetIncome: -15699000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/725058/0001193125-05-052592.txt#8783 The citation records this snapshot. The page link may show a newer release later.	−USD 8.25 million Exact value Exact value: -8251000 USD 2002-01-01 – 2002-12-31: -8251000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CYTOGEN CORP · 2002-12-31 CYTOGEN CORP (edgar:725058) Operating Cash Flow: -8251000 USD Concept: fundies:OperatingCashFlow Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T17:47:15Z Snapshot: 9d0200b53e978d12715361cbdd57098270ba2352acbb158e353e2872feebe7ce Dimensions: Consolidated View: https://fundies.io/companies/edgar/725058/explain?concept=fundies%3AOperatingCashFlow&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -8251000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/725058/0001193125-05-052592.txt#9035 The citation records this snapshot. The page link may show a newer release later.	USD 148,000 Exact value Exact value: 148000 USD 2002-01-01 – 2002-12-31: 148000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CYTOGEN CORP · 2002-12-31 CYTOGEN CORP (edgar:725058) Capital Expenditure: 148000 USD Concept: fundies:CapitalExpenditure Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T17:47:15Z Snapshot: 9d0200b53e978d12715361cbdd57098270ba2352acbb158e353e2872feebe7ce Dimensions: Consolidated View: https://fundies.io/companies/edgar/725058/explain?concept=fundies%3ACapitalExpenditure&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 148000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/725058/0001193125-05-052592.txt#9091 The citation records this snapshot. The page link may show a newer release later.	−USD 8.4 million Calculation and evidence -8251000 − 148000 USD Exact free cash flow: -8399000 USD 2002-01-01 – 2002-12-31: -8251000 USD · Inspect Operating Cash Flow · Source 2002-01-01 – 2002-12-31: 148000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CYTOGEN CORP · 2002-12-31 CYTOGEN CORP (edgar:725058) Free cash flow: -8399000 USD Concept: free-cash-flow Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T17:47:15Z Snapshot: 9d0200b53e978d12715361cbdd57098270ba2352acbb158e353e2872feebe7ce Dimensions: Consolidated View: https://fundies.io/companies/edgar/725058?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -8251000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/725058/0001193125-05-052592.txt#9035 Input fundies:CapitalExpenditure: 148000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/725058/0001193125-05-052592.txt#9091 The citation records this snapshot. The page link may show a newer release later.
2003 2003-01-01 – 2003-12-31	−USD 9.36 million Exact value Exact value: -9358000 USD 2003-01-01 – 2003-12-31: -9358000 USD Inspect Net Income Open source Share or cite Citation for Net Income · CYTOGEN CORP · 2003-12-31 CYTOGEN CORP (edgar:725058) Net Income: -9358000 USD Concept: fundies:NetIncome Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T17:47:15Z Snapshot: 9d0200b53e978d12715361cbdd57098270ba2352acbb158e353e2872feebe7ce Dimensions: Consolidated View: https://fundies.io/companies/edgar/725058/explain?concept=fundies%3ANetIncome&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:NetIncome: -9358000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/725058/0001193125-06-056835.txt#8791 The citation records this snapshot. The page link may show a newer release later.	−USD 10.54 million Exact value Exact value: -10543000 USD 2003-01-01 – 2003-12-31: -10543000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CYTOGEN CORP · 2003-12-31 CYTOGEN CORP (edgar:725058) Operating Cash Flow: -10543000 USD Concept: fundies:OperatingCashFlow Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T17:47:15Z Snapshot: 9d0200b53e978d12715361cbdd57098270ba2352acbb158e353e2872feebe7ce Dimensions: Consolidated View: https://fundies.io/companies/edgar/725058/explain?concept=fundies%3AOperatingCashFlow&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -10543000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/725058/0001193125-06-056835.txt#9057 The citation records this snapshot. The page link may show a newer release later.	USD 84,000 Exact value Exact value: 84000 USD 2003-01-01 – 2003-12-31: 84000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CYTOGEN CORP · 2003-12-31 CYTOGEN CORP (edgar:725058) Capital Expenditure: 84000 USD Concept: fundies:CapitalExpenditure Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T17:47:15Z Snapshot: 9d0200b53e978d12715361cbdd57098270ba2352acbb158e353e2872feebe7ce Dimensions: Consolidated View: https://fundies.io/companies/edgar/725058/explain?concept=fundies%3ACapitalExpenditure&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 84000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/725058/0001193125-06-056835.txt#9113 The citation records this snapshot. The page link may show a newer release later.	−USD 10.63 million Calculation and evidence -10543000 − 84000 USD Exact free cash flow: -10627000 USD 2003-01-01 – 2003-12-31: -10543000 USD · Inspect Operating Cash Flow · Source 2003-01-01 – 2003-12-31: 84000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CYTOGEN CORP · 2003-12-31 CYTOGEN CORP (edgar:725058) Free cash flow: -10627000 USD Concept: free-cash-flow Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T17:47:15Z Snapshot: 9d0200b53e978d12715361cbdd57098270ba2352acbb158e353e2872feebe7ce Dimensions: Consolidated View: https://fundies.io/companies/edgar/725058?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -10543000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/725058/0001193125-06-056835.txt#9057 Input fundies:CapitalExpenditure: 84000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/725058/0001193125-06-056835.txt#9113 The citation records this snapshot. The page link may show a newer release later.
2004 2004-01-01 – 2004-12-31	−USD 20.54 million Exact value Exact value: -20540000 USD 2004-01-01 – 2004-12-31: -20540000 USD Inspect Net Income Open source Share or cite Citation for Net Income · CYTOGEN CORP · 2004-12-31 CYTOGEN CORP (edgar:725058) Net Income: -20540000 USD Concept: fundies:NetIncome Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T17:47:15Z Snapshot: 9d0200b53e978d12715361cbdd57098270ba2352acbb158e353e2872feebe7ce Dimensions: Consolidated View: https://fundies.io/companies/edgar/725058/explain?concept=fundies%3ANetIncome&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:NetIncome: -20540000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/725058/0001140361-07-005918.txt#21007 The citation records this snapshot. The page link may show a newer release later.	−USD 17.67 million Exact value Exact value: -17673000 USD 2004-01-01 – 2004-12-31: -17673000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CYTOGEN CORP · 2004-12-31 CYTOGEN CORP (edgar:725058) Operating Cash Flow: -17673000 USD Concept: fundies:OperatingCashFlow Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T17:47:15Z Snapshot: 9d0200b53e978d12715361cbdd57098270ba2352acbb158e353e2872feebe7ce Dimensions: Consolidated View: https://fundies.io/companies/edgar/725058/explain?concept=fundies%3AOperatingCashFlow&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -17673000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/725058/0001140361-07-005918.txt#21414 The citation records this snapshot. The page link may show a newer release later.	USD 695,000 Exact value Exact value: 695000 USD 2004-01-01 – 2004-12-31: 695000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CYTOGEN CORP · 2004-12-31 CYTOGEN CORP (edgar:725058) Capital Expenditure: 695000 USD Concept: fundies:CapitalExpenditure Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T17:47:15Z Snapshot: 9d0200b53e978d12715361cbdd57098270ba2352acbb158e353e2872feebe7ce Dimensions: Consolidated View: https://fundies.io/companies/edgar/725058/explain?concept=fundies%3ACapitalExpenditure&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 695000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/725058/0001140361-07-005918.txt#21487 The citation records this snapshot. The page link may show a newer release later.	−USD 18.37 million Calculation and evidence -17673000 − 695000 USD Exact free cash flow: -18368000 USD 2004-01-01 – 2004-12-31: -17673000 USD · Inspect Operating Cash Flow · Source 2004-01-01 – 2004-12-31: 695000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CYTOGEN CORP · 2004-12-31 CYTOGEN CORP (edgar:725058) Free cash flow: -18368000 USD Concept: free-cash-flow Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T17:47:15Z Snapshot: 9d0200b53e978d12715361cbdd57098270ba2352acbb158e353e2872feebe7ce Dimensions: Consolidated View: https://fundies.io/companies/edgar/725058?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -17673000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/725058/0001140361-07-005918.txt#21414 Input fundies:CapitalExpenditure: 695000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/725058/0001140361-07-005918.txt#21487 The citation records this snapshot. The page link may show a newer release later.
2005 2005-01-01 – 2005-12-31	−USD 26.29 million Exact value Exact value: -26289000 USD 2005-01-01 – 2005-12-31: -26289000 USD Inspect Net Income Open source Share or cite Citation for Net Income · CYTOGEN CORP · 2005-12-31 CYTOGEN CORP (edgar:725058) Net Income: -26289000 USD Concept: fundies:NetIncome Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T17:47:15Z Snapshot: 9d0200b53e978d12715361cbdd57098270ba2352acbb158e353e2872feebe7ce Dimensions: Consolidated View: https://fundies.io/companies/edgar/725058/explain?concept=fundies%3ANetIncome&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:NetIncome: -26289000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/725058/0000725058-08-000009.txt#18056 The citation records this snapshot. The page link may show a newer release later.	−USD 29.47 million Exact value Exact value: -29468000 USD 2005-01-01 – 2005-12-31: -29468000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CYTOGEN CORP · 2005-12-31 CYTOGEN CORP (edgar:725058) Operating Cash Flow: -29468000 USD Concept: fundies:OperatingCashFlow Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T17:47:15Z Snapshot: 9d0200b53e978d12715361cbdd57098270ba2352acbb158e353e2872feebe7ce Dimensions: Consolidated View: https://fundies.io/companies/edgar/725058/explain?concept=fundies%3AOperatingCashFlow&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -29468000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/725058/0000725058-08-000009.txt#18377 The citation records this snapshot. The page link may show a newer release later.	USD 405,000 Exact value Exact value: 405000 USD 2005-01-01 – 2005-12-31: 405000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CYTOGEN CORP · 2005-12-31 CYTOGEN CORP (edgar:725058) Capital Expenditure: 405000 USD Concept: fundies:CapitalExpenditure Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T17:47:15Z Snapshot: 9d0200b53e978d12715361cbdd57098270ba2352acbb158e353e2872feebe7ce Dimensions: Consolidated View: https://fundies.io/companies/edgar/725058/explain?concept=fundies%3ACapitalExpenditure&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 405000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/725058/0000725058-08-000009.txt#18447 The citation records this snapshot. The page link may show a newer release later.	−USD 29.87 million Calculation and evidence -29468000 − 405000 USD Exact free cash flow: -29873000 USD 2005-01-01 – 2005-12-31: -29468000 USD · Inspect Operating Cash Flow · Source 2005-01-01 – 2005-12-31: 405000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CYTOGEN CORP · 2005-12-31 CYTOGEN CORP (edgar:725058) Free cash flow: -29873000 USD Concept: free-cash-flow Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T17:47:15Z Snapshot: 9d0200b53e978d12715361cbdd57098270ba2352acbb158e353e2872feebe7ce Dimensions: Consolidated View: https://fundies.io/companies/edgar/725058?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -29468000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/725058/0000725058-08-000009.txt#18377 Input fundies:CapitalExpenditure: 405000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/725058/0000725058-08-000009.txt#18447 The citation records this snapshot. The page link may show a newer release later.
2006 2006-01-01 – 2006-12-31	−USD 15.1 million Exact value Exact value: -15103000 USD 2006-01-01 – 2006-12-31: -15103000 USD Inspect Net Income Open source Share or cite Citation for Net Income · CYTOGEN CORP · 2006-12-31 CYTOGEN CORP (edgar:725058) Net Income: -15103000 USD Concept: fundies:NetIncome Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T17:47:15Z Snapshot: 9d0200b53e978d12715361cbdd57098270ba2352acbb158e353e2872feebe7ce Dimensions: Consolidated View: https://fundies.io/companies/edgar/725058/explain?concept=fundies%3ANetIncome&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:NetIncome: -15103000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/725058/0000725058-08-000009.txt#18056 The citation records this snapshot. The page link may show a newer release later.	−USD 22.85 million Exact value Exact value: -22853000 USD 2006-01-01 – 2006-12-31: -22853000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CYTOGEN CORP · 2006-12-31 CYTOGEN CORP (edgar:725058) Operating Cash Flow: -22853000 USD Concept: fundies:OperatingCashFlow Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T17:47:15Z Snapshot: 9d0200b53e978d12715361cbdd57098270ba2352acbb158e353e2872feebe7ce Dimensions: Consolidated View: https://fundies.io/companies/edgar/725058/explain?concept=fundies%3AOperatingCashFlow&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -22853000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/725058/0000725058-08-000009.txt#18377 The citation records this snapshot. The page link may show a newer release later.	USD 171,000 Exact value Exact value: 171000 USD 2006-01-01 – 2006-12-31: 171000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CYTOGEN CORP · 2006-12-31 CYTOGEN CORP (edgar:725058) Capital Expenditure: 171000 USD Concept: fundies:CapitalExpenditure Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T17:47:15Z Snapshot: 9d0200b53e978d12715361cbdd57098270ba2352acbb158e353e2872feebe7ce Dimensions: Consolidated View: https://fundies.io/companies/edgar/725058/explain?concept=fundies%3ACapitalExpenditure&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 171000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/725058/0000725058-08-000009.txt#18447 The citation records this snapshot. The page link may show a newer release later.	−USD 23.02 million Calculation and evidence -22853000 − 171000 USD Exact free cash flow: -23024000 USD 2006-01-01 – 2006-12-31: -22853000 USD · Inspect Operating Cash Flow · Source 2006-01-01 – 2006-12-31: 171000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CYTOGEN CORP · 2006-12-31 CYTOGEN CORP (edgar:725058) Free cash flow: -23024000 USD Concept: free-cash-flow Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T17:47:15Z Snapshot: 9d0200b53e978d12715361cbdd57098270ba2352acbb158e353e2872feebe7ce Dimensions: Consolidated View: https://fundies.io/companies/edgar/725058?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -22853000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/725058/0000725058-08-000009.txt#18377 Input fundies:CapitalExpenditure: 171000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/725058/0000725058-08-000009.txt#18447 The citation records this snapshot. The page link may show a newer release later.
2007 2007-01-01 – 2007-12-31	−USD 25.69 million Exact value Exact value: -25692000 USD 2007-01-01 – 2007-12-31: -25692000 USD Inspect Net Income Open source Share or cite Citation for Net Income · CYTOGEN CORP · 2007-12-31 CYTOGEN CORP (edgar:725058) Net Income: -25692000 USD Concept: fundies:NetIncome Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T17:47:15Z Snapshot: 9d0200b53e978d12715361cbdd57098270ba2352acbb158e353e2872feebe7ce Dimensions: Consolidated View: https://fundies.io/companies/edgar/725058/explain?concept=fundies%3ANetIncome&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:NetIncome: -25692000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/725058/0000725058-08-000009.txt#18056 The citation records this snapshot. The page link may show a newer release later.	−USD 31.13 million Exact value Exact value: -31129000 USD 2007-01-01 – 2007-12-31: -31129000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CYTOGEN CORP · 2007-12-31 CYTOGEN CORP (edgar:725058) Operating Cash Flow: -31129000 USD Concept: fundies:OperatingCashFlow Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T17:47:15Z Snapshot: 9d0200b53e978d12715361cbdd57098270ba2352acbb158e353e2872feebe7ce Dimensions: Consolidated View: https://fundies.io/companies/edgar/725058/explain?concept=fundies%3AOperatingCashFlow&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -31129000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/725058/0000725058-08-000009.txt#18377 The citation records this snapshot. The page link may show a newer release later.	USD 840,000 Exact value Exact value: 840000 USD 2007-01-01 – 2007-12-31: 840000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CYTOGEN CORP · 2007-12-31 CYTOGEN CORP (edgar:725058) Capital Expenditure: 840000 USD Concept: fundies:CapitalExpenditure Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T17:47:15Z Snapshot: 9d0200b53e978d12715361cbdd57098270ba2352acbb158e353e2872feebe7ce Dimensions: Consolidated View: https://fundies.io/companies/edgar/725058/explain?concept=fundies%3ACapitalExpenditure&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 840000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/725058/0000725058-08-000009.txt#18447 The citation records this snapshot. The page link may show a newer release later.	−USD 31.97 million Calculation and evidence -31129000 − 840000 USD Exact free cash flow: -31969000 USD 2007-01-01 – 2007-12-31: -31129000 USD · Inspect Operating Cash Flow · Source 2007-01-01 – 2007-12-31: 840000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CYTOGEN CORP · 2007-12-31 CYTOGEN CORP (edgar:725058) Free cash flow: -31969000 USD Concept: free-cash-flow Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T17:47:15Z Snapshot: 9d0200b53e978d12715361cbdd57098270ba2352acbb158e353e2872feebe7ce Dimensions: Consolidated View: https://fundies.io/companies/edgar/725058?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -31129000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/725058/0000725058-08-000009.txt#18377 Input fundies:CapitalExpenditure: 840000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/725058/0000725058-08-000009.txt#18447 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

63 filings · 0 latest values · 0 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0000725058, 725058, edgar:725058

CYTOGEN CORP

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Trailing twelve months

Net income

Operating cash flow

Capital expenditure

Free cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2007 2007-01-01 – 2007-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation